http://cocomino.wordpress.com/2012/01/26/flu-and-holidays/
Interesting to see that Relenza is still being used by Hospitals in Japan as a first choice antiviral. I guess this is good for Biota because the Royalties on Relenza are be higher than LANI.
Tamiflu is getting bad press in Japan - Relenza and LANI may well dominate this market moving forward.
- Forums
- ASX - By Stock
- BTA
- japan and relenza
japan and relenza
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)